SAN DIEGO, Aug. 30 /PRNewswire/ -- Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain, announced today the appointment of David Cohen to Chief Operating Officer. In his capacity as COO, Mr. Cohen is responsible for new business analysis and development to expand the Company's core business. He also has oversight of Millennium's legislative initiatives and community outreach programs.
"David's track record of success in negotiation fund raising, SEC compliance and investor relations brings tremendous value to Millennium," said James Slattery, Chief Executive Officer. "His experience has already contributed greatly to our expansive growth and enhanced our reputation in the pain management arena."
"It's an honor to take on this new challenge at Millennium and to build on the momentum created by our new marketing, sales and operational initiatives," stated Cohen. "Our customer focus and emphasis on groundbreaking research position us to take Millennium to the next level."
David Cohen originally joined Millennium Laboratories as Chief Analytics Officer. In his 28-year career, Mr. Cohen has served as a public company Chief Financial Officer, Controller and later Executive Vice president of a $500 million dollar real estate conglomerate operating in 38 states and the commonwealth of Guam. He has also been involved with several start-ups and turnaround situations. His reputation as a skilled negotiator is well-earned – he has raised more than $35 million for specific projects in private